REGENXBIO, Inc. (RGNX)
8.925
-0.28
(-2.99%)
USD |
NASDAQ |
Sep 04, 16:00
8.925
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Cash and Short Term Investments (Annual) : 230.07M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 230.07M |
| December 31, 2024 | 234.69M |
| December 31, 2023 | 275.26M |
| December 31, 2022 | 364.64M |
| December 31, 2021 | 457.44M |
| December 31, 2020 | 475.74M |
| December 31, 2019 | 296.21M |
| Date | Value |
|---|---|
| December 31, 2018 | 319.76M |
| December 31, 2017 | 160.78M |
| December 31, 2016 | 89.55M |
| December 31, 2015 | 114.14M |
| December 31, 2014 | 1.121M |
| December 31, 2013 | 1.119M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AbbVie, Inc. | 5.257B |
| Capricor Therapeutics, Inc. | 318.13M |
| Biogen, Inc. | 3.816B |
| United Therapeutics Corp. | 2.920B |
| Ardelyx, Inc. | 264.69M |